Wordt geladen...
Bleomycin in Octaarginine-modified Fusogenic Liposomes Results in Improved Tumor Growth Inhibition
Bleomycin (BLM) is an example of an anticancer drug that should be delivered into cytosol for its efficient therapeutic action. With this in mind, we developed octaarginine (R8)-modified fusogenic DOPE-liposomes (R8-DOPE-BLM). R8-modification dramatically increased (up to 50-fold) the cell-liposome...
Bewaard in:
| Hoofdauteurs: | , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
2012
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3470833/ https://ncbi.nlm.nih.gov/pubmed/22743614 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.canlet.2012.06.008 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|